Fischer Medical Ventures Appoints David Yeow as Independent Director, Reconstitutes Audit Committee
Fischer Medical Ventures appointed Mr. David Yeow as Additional Independent Director from September 3, 2026. The Audit Committee was reconstituted. The 33rd AGM will be held on September 29, 2026. The register of members will close from September 23 to September 29, 2026.
The appointment of a new independent director and the reconstitution of the audit committee are significant for corporate governance. The scheduling of the AGM and closure of the register of members are also important procedural events impacting shareholders.
The announcement details routine corporate governance actions such as the appointment of an independent director, reconstitution of a committee, and scheduling of the AGM. These are standard procedural events with no immediate positive or negative financial implications mentioned.
Fischer Medical Ventures Limited (formerly Fischer Chemic Limited) announced the outcome of its Board Meeting held on September 3, 2026. The Board approved the appointment of Mr. David Yeow as an Additional Independent Director (DIN: 11923054) with effect from September 3, 2026, for a term of five years, subject to shareholder approval.
Following this appointment, the Board also approved the reconstitution of the Audit Committee, with Mr. David Yeow joining as a Member. The Audit Committee now includes Mr. Khairy Jamaluddin Abu Bakar (Chairman), Ms. Jaya Ankur Singhania, Mr. Chan Sing En, Dr. Syed Jalaludin, and Mr. David Yeow as Independent Directors, along with Mr. Ravindran Govindan (Executive Director) and Ms. Svetlana Rao Raviwada (Whole Time Director).
The 33rd Annual General Meeting (AGM) of the Company is scheduled to be held on Tuesday, September 29, 2026, at 11:00 AM IST, through video conferencing. M/s Nuren Lodaya & Associates, Practicing Company Secretary, Mumbai, has been appointed as the scrutinizer for the e-voting process.
Furthermore, the company informed that the register of members will remain closed from September 23, 2026, to September 29, 2026, both days inclusive, for the purpose of the AGM. The Board Meeting commenced at 11:15 AM IST and concluded at 02:20 PM IST.
A plain-language summary of a public exchange filing by Fischer Medical Ventures Limited. Read the original for the full detail.